1. Pisarski K. The Global Burden of Disease of Zoonotic Parasitic Diseases: Top 5 Contenders for Priority Consideration. Trop Med Infect Dis. 2019; 2;4(1):44.
2. Campbell, S.; Soman-Faulkner, K. Antiparasitic Drugs. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA, 2022.
3. Gonzalez-Pastor R, Carrera-Pacheco SE, Zúñiga-Miranda J, et al. Current Landscape of Methods to Evaluate Antimicrobial Activity of Natural Extracts. Molecules. 2023; 20;28(3):1068.
4. Gulsen SH, Tileklioglu E, Bode E, et al. Antiprotozoal activity of different Xenorhabdus and Photorhabdus bacterial secondary metabolites and identification of bioactive compounds using
the easyPACId approach. Sci Rep. 2022; 24;12(1):10779.
5. Goupil LS, McKerrow JH. Introduction: drug discovery and development for neglected diseases. Chem Rev. 2014; 26;114(22):11131-7.
6. Das K, Tiwari RKS, Shrivastava DK. Techniques for evaluation of medicinal plant products as antimicrobial agent: Current methods and future trends. J. Med. Plant Res. 2010; 4(2), 104-111.
7. Yildiz I, Yilmaz O, Tileklioglu E, Sakarya S, Ertabaklar H. Stabilised Hypochlorous Acid: A New Therapeutic Strategy Against Dangerous Parasitic Eye Infection Agent Acanthamoeba
spp. J. Environ. Prot. Ecol., 2018; 19(3), 1397-1404.
8. Doonan F, Cotter TG. Morphological assessment of apoptosis. Methods. 2008;44(3):200-4.
9. Adan A, Alizada G, Kiraz Y, Baran Y, Nalbant A. Flow cytometry: basic principles and applications. Crit Rev Biotechnol. 2017; 37(2):163-176.
10. Bass CC. A new conception of immunity: Its application to the cultivation of protozoa and bacteria from the blood and to therapeutic measures. JAMA, 1011; 57(19), 1534-1535.
11. Maji AK. Drug susceptibility testing methods of antimalarial agents. Trop Parasitol. 2018; 8(2):70-76.
12. Yildiz İ, Tileklioğlu E, Yilmaz Ö, Ertabaklar H, Sakarya S. Stabilized hypochlorous acid, a topical therapeutic strategy for Trichomonas vaginalis infection: An in vitro study. Parasitol. United
J, 2020; 13(1), 60-65.
13. Ozbilgin A, Durmuskahya C, Kayalar H, et al. Antileishmanial activity of selected turkish medicinal plants. Trop. J. Pharm. Res, 2014; 13(12), 2047-2055.
14. Özbilgin A, Çavuş İ, Yıldırım A, Kaya T, Ertabaklar H. Evaluation of In vitro and In vivo Drug Efficacy Over Leishmania tropica: A Pilot Study. Turkiye Parazitol Derg. 2018; 42(1):11-19.
15. Ogungbe IV, Setzer WN. In-silico Leishmania target selectivity of antiparasitic terpenoids. Molecules. 2013; 3;18(7):7761-847.
16. Johnson RM, Rawson S, McPhillie MJ, Fishwick CWG, Muench SP. The Growing Role of Electron Microscopy in Anti-parasitic Drug Discovery. Curr Med Chem. 2018;25(39):5279-5290.
17. Weng HB, Chen HX, Wang MW. Innovation in neglected tropical disease drug discovery and development. Infect Dis Poverty. 2018; 18;7(1):67.
18. Villalta F, Rachakonda G. Advances in preclinical approaches to Chagas disease drug discovery. Expert Opin Drug Discov. 2019; 14(11):1161-1174.
19. Cowell AN, Winzeler EA. Advances in omics-based methods to identify novel targets for malaria and other parasitic protozoan infections. Genome Med. 2019; 22;11(1):63. doi: 10.1186/
s13073-019-0673-3.
20. Balouiri M, Sadiki M, Ibnsouda SK. Methods for in vitro evaluating antimicrobial activity: A review. J Pharm Anal. 2016; 6(2):71-79.
21. Finger S, Wiegand C, Buschmann HJ, Hipler UC. Antibacterial properties of cyclodextrin-antiseptics-complexes determined by microplate laser nephelometry and ATP bioluminescence
assay. Int J Pharm. 2013;16;452(1-2):188-93.
22. Rieckmann KH, Campbell GH, Sax LJ, Mrema JE. Drug sensitivity of plasmodium falciparum. An in-vitro microtechnique. Lancet. 1978; 7;1(8054):22-3.
23. Makler MT, Ries JM, Williams JA, et al. Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. Am J Trop Med Hyg. 1993; 48(6):739-41.
24. Munguía B, Saldaña J, Nieves M, et al. Sensitivity of Haemonchus contortus to anthelmintics using different in vitro screening assays: a comparative study. Parasit Vectors. 2022; 12;15(1):129.
25. Zenebe S, Feyera T, Assefa S. In Vitro Anthelmintic Activity of Crude Extracts of Aerial Parts of Cissus quadrangularis L. and Leaves of Schinus molle L. against Haemonchus contortus.
Biomed Res Int. 2017; 2017:1905987.
26. Jayawardene KLTD, Palombo EA, Boag PR. Natural Products Are a Promising Source for Anthelmintic Drug Discovery. Biomolecules. 2021; 4;11(10):1457.
27. Carvalho CO, Chagas AC, Cotinguiba F, et al. The anthelmintic effect of plant extracts on Haemonchus contortus and Strongyloides venezuelensis. Vet Parasitol. 2012; 10;183(3-4):260-8.
28. Maestrini M, Tava A, Mancini S, Tedesco D, Perrucci S. In Vitro Anthelmintic Activity of Saponins from Medicago spp. Against Sheep Gastrointestinal Nematodes. Molecules. 2020;
7;25(2):242.
29. Eguale T, Tadesse D, Giday M. In vitro anthelmintic activity of crude extracts of five medicinal plants against egg-hatching and larval development of Haemonchus contortus. J Ethnopharma-
col. 2011; 1;137(1):108-13.
30. Giovanelli F, Mattellini M, Fichi G, Flamini G, Perrucci S. In Vitro Anthelmintic Activity of Four Plant-Derived Compounds against Sheep Gastrointestinal Nematodes. Vet Sci. 2018;
10;5(3):78.
31. Garbin VP, Munguía B, Saldaña JC, Deschamps C, Cipriano RR, Molento MB. Chemical characterization and in vitro anthelmintic activity of Citrus bergamia Risso and Citrus X paradisii
Macfad essential oil against Haemonchus contortus Kirby isolate. Acta Trop. 2021; 217:105869.
32. Vijayakumar S, Malaikozhundan B, Saravanakumar K, Durán-Lara EF, Wang MH, Vaseeharan B. Garlic clove extract assisted silver nanoparticle – Antibacterial, antibiofilm, antihelminthic,
anti-inflammatory, anticancer and ecotoxicity assessment. J Photochem Photobiol B. 2019; 198:111558